Cancers by number of trials

JSON

Cancers ordered by how many trial records in the corpus name them. Top 50 of 296 cancers with a value; ties are broken by name. 5,946 of 5,969 trials name at least one cancer (100%).

#	Cancer	Trials	Approved products
1	Non-small-cell lung cancer	709	88 approved products
2	Rectal cancer	614	1 approved product
3	Metastatic cancer (cancer that has spread)	570	0 approved products
4	Colon cancer (adenocarcinoma of the colon)	462	0 approved products
5	Small-cell lung cancer	393	14 approved products
6	Prostate cancer	302	34 approved products
7	Colorectal cancer	301	46 approved products
8	Metastatic pancreatic ductal adenocarcinoma	249	5 approved products
9	Pancreatic ductal adenocarcinoma	222	35 approved products
10	Biliary tract cancer (cholangiocarcinoma)	205	12 approved products
11	Gallbladder cancer	170	6 approved products
12	Ovarian cancer	166	22 approved products
13	Early triple-negative breast cancer	165	6 approved products
14	Multiple myeloma	162	26 approved products
15	HR-positive / HER2-negative breast cancer	155	54 approved products
16	Metastatic triple-negative breast cancer	154	13 approved products
17	EGFR-mutated non-small-cell lung cancer	152	10 approved products
18	Triple-negative breast cancer (TNBC)	146	35 approved products
19	Melanoma	145	23 approved products
20	Non-Hodgkin lymphoma (all types)	143	2 approved products
21	Biliary tract cancer (all types)	134	4 approved products
22	Head and neck squamous cell carcinoma	130	14 approved products
23	Breast cancer (all types)	128	1 approved product
24	Resectable stage I to III non-small-cell lung cancer	121	8 approved products
25	HER2-positive breast cancer	120	18 approved products
26	Locally advanced unresectable pancreatic ductal adenocarcinoma	111	1 approved product
27	Bladder & urothelial cancer	107	24 approved products
28	Hepatocellular carcinoma	104	18 approved products
29	Metastatic castration-resistant prostate cancer	103	10 approved products
30	Resectable pancreatic ductal adenocarcinoma	101	2 approved products
31	Gastric & gastro-oesophageal junction cancer	100	28 approved products
32	Diffuse large B-cell lymphoma	98	31 approved products
33	Relapsed or refractory multiple myeloma	89	10 approved products
34	Glioma & glioblastoma	86	11 approved products
35	Mismatch-repair deficient (MSI-high) colorectal cancer	86	4 approved products
36	Acute myeloid leukaemia	84	30 approved products
37	Intrahepatic cholangiocarcinoma	84	4 approved products
38	Extensive-stage small-cell lung cancer	80	8 approved products
39	Endometrial cancer	77	9 approved products
40	Extrahepatic cholangiocarcinoma (perihilar and distal)	77	1 approved product
41	Renal cell carcinoma	72	18 approved products
42	Chronic lymphocytic leukaemia	69	20 approved products
43	Cervical cancer	66	15 approved products
44	Hodgkin lymphoma	61	17 approved products
45	Acute lymphoblastic leukaemia	60	30 approved products
46	Advanced melanoma (unresectable stage III and stage IV)	60	12 approved products
47	Oesophageal cancer	58	7 approved products
48	Follicular lymphoma	57	7 approved products
49	Lung cancer (all types)	55	30 approved products
50	Sarcomas (soft tissue, bone, GIST)	51	22 approved products

246 more cancers have a value below the top 50; the full list of cancers is at /cancers/.

How this is counted

Counts trial records whose cancers field lists the cancer. Trials that name several cancers count once for each. The context column counts products with status approved that list the cancer. Supportive care medicines (antiemetics, growth factors, epoetins, bone-modifying agents, antidotes, opioids for cancer pain, immunoglobulin; drug records flagged supportive) are not products or treatments here and are left out.

Coverage. 5,946 of 5,969 trials name at least one cancer (100%). Rows with a value of zero are not listed. Nothing is weighted, imputed or averaged; the ordering is by the number shown, then by name.

Machine-readable copy: /rankings/cancers-by-trials/data.json. Registry: src/lib/rankings.ts.

Cancers by number of trials

How this is counted

Other rankings

Cancers by number of trials

How this is counted

Other rankings